We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Intuitive Surgical, Inc. (ISRG) Stock Falls Amid Market Uptick: What Investors Need to Know
Read MoreHide Full Article
In the latest close session, Intuitive Surgical, Inc. (ISRG - Free Report) was down 3.76% at $449.98. This move lagged the S&P 500's daily gain of 0.3%. Meanwhile, the Dow lost 0.48%, and the Nasdaq, a tech-heavy index, added 0.03%.
The stock of company has fallen by 2.23% in the past month, lagging the Medical sector's gain of 7.07% and the S&P 500's gain of 2.09%.
The investment community will be paying close attention to the earnings performance of Intuitive Surgical, Inc. in its upcoming release. The company's upcoming EPS is projected at $2, signifying a 8.70% increase compared to the same quarter of the previous year. At the same time, our most recent consensus estimate is projecting a revenue of $2.41 billion, reflecting a 18.22% rise from the equivalent quarter last year.
Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of $8.17 per share and revenue of $9.78 billion. These totals would mark changes of +11.31% and +17.1%, respectively, from last year.
Investors should also pay attention to any latest changes in analyst estimates for Intuitive Surgical, Inc. Recent revisions tend to reflect the latest near-term business trends. As such, positive estimate revisions reflect analyst optimism about the business and profitability.
Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
The Zacks Rank system, running from #1 (Strong Buy) to #5 (Strong Sell), holds an admirable track record of superior performance, independently audited, with #1 stocks contributing an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection remained stagnant. At present, Intuitive Surgical, Inc. boasts a Zacks Rank of #3 (Hold).
Investors should also note Intuitive Surgical, Inc.'s current valuation metrics, including its Forward P/E ratio of 57.22. This valuation marks a premium compared to its industry average Forward P/E of 23.97.
Also, we should mention that ISRG has a PEG ratio of 3.92. The PEG ratio bears resemblance to the frequently used P/E ratio, but this parameter also includes the company's expected earnings growth trajectory. Medical - Instruments stocks are, on average, holding a PEG ratio of 2.57 based on yesterday's closing prices.
The Medical - Instruments industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 144, which puts it in the bottom 42% of all 250+ industries.
The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Keep in mind to rely on Zacks.com to watch all these stock-impacting metrics, and more, in the succeeding trading sessions.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Intuitive Surgical, Inc. (ISRG) Stock Falls Amid Market Uptick: What Investors Need to Know
In the latest close session, Intuitive Surgical, Inc. (ISRG - Free Report) was down 3.76% at $449.98. This move lagged the S&P 500's daily gain of 0.3%. Meanwhile, the Dow lost 0.48%, and the Nasdaq, a tech-heavy index, added 0.03%.
The stock of company has fallen by 2.23% in the past month, lagging the Medical sector's gain of 7.07% and the S&P 500's gain of 2.09%.
The investment community will be paying close attention to the earnings performance of Intuitive Surgical, Inc. in its upcoming release. The company's upcoming EPS is projected at $2, signifying a 8.70% increase compared to the same quarter of the previous year. At the same time, our most recent consensus estimate is projecting a revenue of $2.41 billion, reflecting a 18.22% rise from the equivalent quarter last year.
Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of $8.17 per share and revenue of $9.78 billion. These totals would mark changes of +11.31% and +17.1%, respectively, from last year.
Investors should also pay attention to any latest changes in analyst estimates for Intuitive Surgical, Inc. Recent revisions tend to reflect the latest near-term business trends. As such, positive estimate revisions reflect analyst optimism about the business and profitability.
Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
The Zacks Rank system, running from #1 (Strong Buy) to #5 (Strong Sell), holds an admirable track record of superior performance, independently audited, with #1 stocks contributing an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection remained stagnant. At present, Intuitive Surgical, Inc. boasts a Zacks Rank of #3 (Hold).
Investors should also note Intuitive Surgical, Inc.'s current valuation metrics, including its Forward P/E ratio of 57.22. This valuation marks a premium compared to its industry average Forward P/E of 23.97.
Also, we should mention that ISRG has a PEG ratio of 3.92. The PEG ratio bears resemblance to the frequently used P/E ratio, but this parameter also includes the company's expected earnings growth trajectory. Medical - Instruments stocks are, on average, holding a PEG ratio of 2.57 based on yesterday's closing prices.
The Medical - Instruments industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 144, which puts it in the bottom 42% of all 250+ industries.
The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Keep in mind to rely on Zacks.com to watch all these stock-impacting metrics, and more, in the succeeding trading sessions.